This website uses cookies

Read our Privacy policy and Terms of use for more information.

MiniMed has begun commercial shipments of its MiniMed Flex insulin pump across Europe, following an initial customer experience phase in select markets. Flex is the company’s smallest automated insulin delivery system to date and its first pump controlled entirely through a smartphone app. The screenless design brings MiniMed’s SmartGuard technology to a more compact system, which is about half the size of the MiniMed 780G.

MiniMed Flex holds up to 300 units of insulin and works with a variety of infusion sets including the company’s Extended infusion set, which can be worn for up to seven days. The system uses the same SmartGuard algorithm as the 780G, automatically adjusting insulin delivery every five minutes based on CGM readings and offering Meal Detection technology to help compensate for missed or underestimated meal boluses. Flex is launching in Europe with the Simplera Sync CGM, with compatibility for Abbott’s 15-day Instinct sensor planned for 2027. The system is CE marked for people ages 2 and older with insulin-treated diabetes, including type 1 and type 2 diabetes, and is also cleared for use during pregnancy.

The European launch comes as MiniMed continues expanding its product lineup. The company recently received FDA clearance for MiniMed Fit, its first tubeless insulin pump, which offers up to seven days of wear and a 300-unit insulin capacity. A phased U.S. rollout is expected to begin in the first-half of 2027. No word on if or when the patch pump system will launch in Europe.

MiniMed is also developing Vivera, a next-generation algorithm, designed to make meal announcements optional. Vivera is not yet approved or commercially available, but MiniMed plans to bring the upgraded technology to its future systems, including Flex and Fit.



DISCLAIMER: Diabetech content is not medical advice — it’s for educational purposes only. Always consult with your healthcare team before making changes to your treatment.


Keep Reading

View more
caret-right